홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ADIL
#4023
Adial Pharmaceuticals, Inc
2.5
3
+3.27%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+3.27%
월간 변동
+1000.00%
6달 변화
+548.72%
년간 변동율
+232.89%
이전 종가
2.4
5
Open
2.5
3
Bid
Ask
Low
2.5
3
High
2.5
3
양
1
마켓
주식
헬스케어
ADIL
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
256.23 K
262.98 K
316.03 K
873.13 K
959.5 K
—
Valuation ratios
Enterprise value
-4.95 M
-3.48 M
-2.17 M
-5.65 M
-4.27 M
-15.57 M
Price to earnings ratio
-0.01
-0.01
-0.03
-0.03
-0.09
-0.16
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-0.02
-0.03
-0.02
-0.01
-0.02
-0.07
Price to book ratio
0.01
0.05
0.01
0
0.01
0.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.33
-0.41
-0.65
-0.29
-0.32
-1.66
Return on equity %
-0.37
-0.51
-1.05
-0.35
-0.4
-2.31
Return on invested capital %
-786.5
-650.24
—
—
—
—
Gross margin %
—
—
100
—
—
—
Operating margin %
—
—
-1 511.53
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
-1 485.87
—
—
—
Liquidity ratios
Quick ratio
—
3.69
—
—
—
—
Current ratio
6.78
4.16
1.99
5.02
4.34
15.51
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0.04
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-7.26
-7.49
-6.06
-4.12
-2.07
-19.74
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
22.3
19.33
9.04
13.92
5.19
47.49
Net current asset value per share
24.07
20.92
10.05
14.31
5.65
50.93
Tangible book value per share
25.19
20.95
8.12
13.15
5.08
47.29
Working capital per share
20.52
15.89
4.99
11.46
4.35
36.68
Book value per share
25.21
20.96
8.13
13.16
5.08
47.33
뉴스
Adial Pharmaceuticals, FDA 정책 변화에 주가 상승
Adial Pharmaceuticals stock rises on FDA policy shift
AD04 임상, Adial, 단일 핵심 시험 경로 모색
Adial Pharmaceuticals eyes single pivotal trial path for AD04
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com
Adial Pharmaceuticals, 1대 25 역분할 발표 후 주가 급락
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split
애디얼 제약, 1대 25 역주식 병합 발표
Adial Pharmaceuticals announces 1-for-25 reverse stock split
애디얼 제약, 이사회 멤버 제임스 W. 뉴먼 주니어 사임 발표
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr.
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?